Navigation Links
Natural Nutrition Interactive Subsidiary Reports Fifteen Percent Revenue Increase in October
Date:11/5/2007

HOUSTON, Nov. 5 /PRNewswire-FirstCall/ -- Natural Nutrition, Inc. (OTC Bulletin Board: NNTN) announced today that its operating subsidiary, InterACTIVE Nutrition, Inc. (INII) http://www.interactivenutrition.com achieved October, 2007 sales of $1,558,000 (CDN). This was a fifteen percent increase in revenue over October, 2006 sales of $1,353,000.

Trevor Holroyd, General Manager of Interactive operations in Canada, stated, "Interactive Nutrition continues to post solid sales increases in our nutritional supplement manufacturing and sales operations in Ottawa, Canada. Since the takeover of operations by Natural Nutrition in May we have seen not only record sales, but a general increase in morale and enthusiasm of the InterACTIVE employees about the future of the company. We are all proud to be part of the Natural Nutrition team."

About Natural Nutrition and InterACTIVE Nutrition, Inc.

InterACTIVE Nutrition International Inc., is partially owned by Corporate Strategies Merchant Bankers, and is a majority owned subsidiary of publicly traded Natural Nutrition, Inc. (OTCBB: NNTN). InterACTIVE Nutrition is an international leader in sports and nutritional supplements backed by over 10 years of research, development and sales of sports nutrition products in over fifteen countries throughout the world. InterACTIVE Nutrition's trusted products are scientifically formulated, and manufactured to improve athletic performance and overall health. For more information on any of InterACTIVE Nutrition's products, please visit http://www.interactivenutrition.com .

This press release contains forward-looking statements, which involve known and unknown risks, uncertainties or other factors that could cause actual results to materially differ from the results, performance or other expectations implied by these forward-looking statem
'/>"/>

SOURCE Natural Nutrition, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Scientists Develop Natural Protection for Stored Foods
2. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
3. SIV infection of natural hosts provides new insights into HIV disease complexity
4. Big Relief for Tiny Itch Mites Found in All Natural Spray Remedy
5. Natural aorta grafts have few side effects for infection-prone patients
6. Fitness Champion Natalie Waples to be Spokesperson for Natural Nutrition International Direct Marketing Campaign
7. New Herbal Water Creating Taste Sensation: Ayalas Herbal Water Has No Calories, No Preservatives and No Artificial Additives. Just All the Natural Benefits of Herbs!
8. Natural Protein Could Help Spot, Treat Liver Cancer
9. The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments
10. All-Natural Organic Yerba Mate and Organic Aloe Vera Exfoliating Soaps will Help Save Your Skin(TM)
11. New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...ecedented medical, economic burdens, study predict...- The number of people with diabetes in the United...rs, a new study predicts. , That would bring th...the disease, up from 23.7 million today. , , At ...abetes will triple, the study also warns, rising f...
(Date:11/27/2009)...hree new interactive anatomy education apps from M...nd health sciences learning opportunities for iPho...m, NC (Vocus) November 27, 2009 -- Modality, Inc....ivision of Wolters Kluwer Health, today announced ...ps on the App Store. Clemente’s Anatomy, Roh...
(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...gate Endpoints of Long-Term Survival in Prostate C...ant metastases 3 years after the start of treatmen...l in patients with early prostate cancer. , Prost...cause patients must be followed for many years. If...
...ity improved 22 percent as a result of My Health p...ated Benefits Institute (IBI) and the National Bus...e Mutual Insurance Company with the 2009 IBI/NBCH ... Reuters, recognizes leadership in the area of hea...
...r to have an effect on whether a patient with term...to a study led by researchers at Beth Israel Deaco...ary 2009 issue of the Journal of the American Ger...s and Hispanics. , According to senior author Ell...
...n Medicine announced today the results from an ong...6 at the 16th Conference on Retroviruses and Oppor... a gene therapy product being investigated for the... from their current antiretroviral therapy. , "W...
...l Insurance Company is one of 10 employers across ...Deserved Award. The award recognizes employers who...yees, health. , , UnitedHealthcare provides healt...ard applicants. Criteria included executive suppor...
...s just-released 2009 AEC Industry Outlook: Strate... reveals a shake-up in the markets that firm lead...ental consulting industries expect to be most prom...e ranked markets (higher education, K-12 schools, ...
Other Medicine News:Health News:Also in the Feb. 10 JNCI 2Health News:Also in the Feb. 10 JNCI 3Health News:Also in the Feb. 10 JNCI 4Health News:Also in the Feb. 10 JNCI 5Health News:Nationwide Receives IBI/NBCH Healthy Workforce Productivity Award 2Health News:Nationwide Receives IBI/NBCH Healthy Workforce Productivity Award 3Health News:Study finds race and ethnicity affect use of hospice services among patients with advanced cancer 2Health News:Penn Medicine presents HIV gene therapy trial data at CROI 2009 2Health News:Texas Mutual Wins National Employee Wellness Award 2Health News:New Study Reveals Shake-Up in the Most Promising AEC Markets for 2009 2
(Date:11/25/2009)...e/ -- Reportlinker.com announces that a new market..., Mammography Equipment - A Global Market Pers...330/Mammography-Equipment---A-Global-Market-Perspe...r in industrialized as well as developing nations ...mmography market. Globally, escalating awareness a...
(Date:11/25/2009)...Newswire/ -- Cempra Pharmaceuticals Inc. today ann...hief executive officer, will present at the Piper ... a.m. EST, December 1, 2009, at The New York Palac...ide an overview of the company,s two leading antib...resistant pathogens including MRSA. ,, About C...
(Date:11/25/2009)...ewswire/ -- ChemoCentryx, Inc., announced today ... PROTECT-1 (the Prospective Randomized Oral Therap...-EN(TM) (CCX282-B) in patients with moderate-to-se...y with a favorable safety and tolerability profile...icacy in the reduction of disease severity as defi...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 1FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 2FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 3FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 4FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 5FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 6FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 7FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 8PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 1PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 3Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 1Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 2Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 3
...ain cell that was long overlooked by researchers e...ain differs fundamentally from that of a mouse or ...findings as the cover story in the March 11 issue ...at the University of Rochester Medical Center fo...ought simply to support flashier brain cells known...
.../ -- Results from the Phase II portion of a Phas...nal drug relaxin for the treatment of acute heart ...day, March 29, at the American College of Cardiolo...do, Fla. , , John R. Teerlink, M.D., professor of... , Director of Heart Failure, San Francisco Vetera...
Other Medicine Technology:Astrocytes Help Separate Man From Mouse 2Astrocytes Help Separate Man From Mouse 3Astrocytes Help Separate Man From Mouse 4Astrocytes Help Separate Man From Mouse 5Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session 2
Kratz-Barraquer Eye Speculum
Lehner Temporal Speculum
Wiener Eye Speculum
McKinney Eye Speculum
Medicine Products: